Applying Precaution in EU Authorisation of Genetically Modified Products-Challenges and Suggestions for Reform
License
Access Rights
Cadmus Permanent Link
Full-text via DOI
ISBN
ISSN
1351-5993
Issue Date
Type of Publication
Keyword(s)
LC Subject Heading
Other Topic(s)
EUI Research Cluster(s)
Initial version
Published version
Succeeding version
Preceding version
Published version part
Earlier different version
Initial format
Author(s)
Citation
European Law Journal, 2010, 16, 5, 624-657
Cite
WEIMER, Maria, Applying Precaution in EU Authorisation of Genetically Modified Products-Challenges and Suggestions for Reform, European Law Journal, 2010, 16, 5, 624-657 - https://hdl.handle.net/1814/16635
Abstract
In this article, I endeavour to examine concrete challenges that arise with regard to implementation of the precautionary principle in the field of European Union regulation of genetically modified organisms (GMOs). Developed by the European courts into a general legal principle, precaution requires EU regulators to strike a balance between scientific and political legitimacy when taking decisions on risk-entailing products. Following this understanding, the current GMO legislation creates precautionary governance structures that allow for a broad input into the authorisation process, not only of scientific, but also of 'other legitimate factors'. At the same time, it can be criticised for narrowly defining precaution as a decision rule, which, if applied correctly, will lead the decision maker to the 'right' decision. I argue that this misconception is one of the reasons why, in the current authorisation practice, the EU institutions fail to apply the principle in a balanced way, falling into the extremes of either purely science-based decision making or a highly politicised precautionary rhetoric. I suggest that in order not to be paralysing, precaution should be understood as a procedural principle that provides for precautionary governance, thus enabling regulators to make appropriate risk choices.